Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-18

Clinical Trial Update: Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental Vitiligo [Phase 2]

View source ↗

Summary

Phase II clinical trial update for MH004 ointment in non-segmental vitiligo; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MH004 Ointment

Snippet

Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd | Conditions: Vitiligo | Phase 2 | Status: ACTIVE_NOT_RECRUITING